The vaccine manufacturer said Monday that a booster dose of its coronavirus vaccine significantly raised antibody levels to protect against the omicron variant, amid growing concerns about its rapid spread in the United States. Those additional antibodies "should provide some good level of protection as we go into the holiday season," Paul Burton, Moderna's chief medical officer, said in an interview. |
No comments:
Post a Comment